Abstract
Objectives
To evaluate myocardial enhancement of patients with cardiac amyloidosis (CA) using computed tomography (CT).
Methods
Thirteen patients with CA and 11 control patients were examined with first-pass and delayed CT acquisition. A qualitative and quantitative analysis of images was performed. Myocardial attenuation, myocardial signal-to-noise ratio (SNRmyoc), blood pool SNR (SNRblood), contrast-to-noise ratio between blood pool and myocardium (CNRblood-myoc) and relative attenuation index (RAI) defined as variation of myocardial attenuation between delayed and first-pass acquisitions were calculated.
Results
Two false negative cases (15 %) and three false positive cases (27 %) were detected on qualitative analysis. SNRmyoc of patients with CA was significantly (p < 0.05) lower on first-pass (4.08 ± 1.9) and higher on delayed acquisition (7.10 ± 2.7) than control patients (6.1 ± 2.2 and 5.03 ± 1.8, respectively). Myocardial attenuation was higher in CA (121 ± 39 HU) than control patients (81 ± 17 HU) on delayed acquisition. CNRblood-myoc was significantly (p < 0.05) lower in CA (1.51 ± 0.7) than control patients (2.85 ± 1.2) on delayed acquisition. The RAI was significantly (p < 0.05) higher in CA (0.12 ± 0.25) than in control patients (−0.56 ± 0.21).
Conclusion
Dual phase MDCT can detect abnormal myocardial enhancement in patients with CA.
Key points
• CT can detect abnormal first-pass and delayed enhancement in cardiac amyloidosis.
• Measurement of relative myocardial enhancement between acquisitions helps to detect cardiac amyloidosis.
• CT may provide useful data to diagnose cardiac amyloidosis.
Similar content being viewed by others
Abbreviations
- CA:
-
Cardiac amyloidosis
- CNR:
-
Contrast-to-noise ratio
- CT:
-
Computed tomography
- LGE:
-
Late gadolinium enhancement
- MDCT:
-
Multidetector computed tomography
- RAI:
-
Relative attenuation index
- SNR:
-
Signal-to-noise ratio
References
Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337:898–909
Koyama J, Falk RH (2010) Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3:333–342
Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S (2007) Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50:2101–2110
Austin BA, Tang WH, Rodriguez ER et al (2009) Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2:1369–1377
Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193
Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54
Syed IS, Glockner JF, Feng D et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3:155–164
Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51:1022–1030
Mark DB, Berman DS, Budoff MJ et al (2010) ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55:2663–2699
Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003
Baks T, Cademartiri F, Moelker AD et al (2007) Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT. AJR Am J Roentgenol 188:W135–W137
Gerber BL, Belge B, Legros GJ et al (2006) Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 113:823–833
Nieman K, Shapiro MD, Ferencik M et al (2008) Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging. Radiology 247:49–56
Rodriguez-Granillo GA, Rosales MA, Baum S et al (2009) Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention. JACC Cardiovasc Imaging 2:1072–1081
Sato A, Nozato T, Hikita H et al (2012) Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction. J Am Coll Cardiol 59:730–738
Zhao L, Ma X, Delano MC et al (2013) Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol 23:1034–1043
Dambrin G, Laissy JP, Serfaty JM, Caussin C, Lancelin B, Paul JF (2007) Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis. A preliminary comparative study with cardiac MRI. Eur Radiol 17:331–338
Bandula S, Banypersad SM, Sado D et al (2013) Measurement of tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging. Radiology 268:858–864
Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 6:34–39
Canet EP, Janier MF, Revel D (1999) Magnetic resonance perfusion imaging in ischemic heart disease. J Magn Reson Imaging 10:423–433
Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 142:619–624
Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474
Bourin M, Jolliet P, Ballereau F (1997) An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet 32:180–193
Paul JF, Wartski M, Caussin C et al (2005) Late defect on delayed contrast-enhanced multi-detector row CT scans in the prediction of SPECT infarct size after reperfused acute myocardial infarction: initial experience. Radiology 236:485–489
Kartje JK, Schmidt B, Bruners P, Mahnken AH (2013) Dual energy CT with nonlinear image blending improves visualization of delayed myocardial contrast enhancement in acute myocardial infarction. Invest Radiol 48:41–45
Acknowledgements
The scientific guarantor of this publication is Jean-François Deux. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, experimental, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deux, JF., Mihalache, CI., Legou, F. et al. Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study. Eur Radiol 25, 2291–2297 (2015). https://doi.org/10.1007/s00330-015-3642-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-3642-2